#215 Retrospective re-evaluation of platinum-free interval and chemotherapeutic effect against subsequent platinum-containing chemotherapy in recurrent ovarian cancer patients initially treated by chemotherapy with bevacizumab
Tamaki Tanaka(Kagawa University), Atsushi Hongo(Okayama University), Kimihiko Ito(Yamagata University), Kazuhiro Takehara(Shikoku Cancer Center), Tomoka Usami, Kotaro Sueoka(Yamaguchi University), Yosuke Konno(Hokkaido University of Science), Shinya Sato(Tokuyama (Japan)), Iemasa Koh(Hiroshima University), Masahiro Kagabu(Iwate Medical University), Hiroko Nakamura(Kure Medical Center), Keiichiro Nakamura, Noriomi Matsumura(Kindai University), Satoe Fujiwara(Osaka University of Pharmaceutical Sciences), Masako Ishikawa(Shimane University), Kei Hirabayashi(Tokuyama (Japan)), Masato Nishimura(Tokushima Prefectural Central Hospital), Eiji Kondo(Mie University), Atsushi Arakawa(Nagoya City University)
Cited by 0
Related Papers
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
Uterine serous carcinoma
|Gynecologic Oncology|2021|158
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status
|Journal of Neurology Neurosurgery & Psychiatry|2012|134
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
|Journal of Translational Medicine|2014|129